A detailed history of Y Intercept (Hong Kong) LTD transactions in Guardant Health, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 11,936 shares of GH stock, worth $376,819. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,936
Previous 50,873 76.54%
Holding current value
$376,819
Previous $1.47 Million 81.42%
% of portfolio
0.02%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$22.3 - $36.29 $868,295 - $1.41 Million
-38,937 Reduced 76.54%
11,936 $273,000
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $421,676 - $835,481
26,240 Added 106.52%
50,873 $1.47 Million
Q1 2024

May 10, 2024

BUY
$17.13 - $26.91 $421,963 - $662,874
24,633 New
24,633 $508,000
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $328,590 - $596,452
-15,692 Reduced 64.74%
8,548 $306,000
Q1 2023

May 09, 2023

BUY
$22.92 - $33.76 $555,580 - $818,342
24,240 New
24,240 $568,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.